In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical ...

GLP-1 medications such as Ozempic, Wegovy and Mounjaro may affect oral health indirectly through dry mouth, vomiting and acid ...

Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss. Although ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...

Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 ...

An experimental weight-loss drug from Eli Lilly led to more than twice the average weight loss of Ozempic in a clinical trial ...

The ‘triple G’ experimental drug also led to greater reductions in A1C. Drugmaker Lilly is expected to apply for FDA approval ...

"Ozempic feet" is an informal term describing heel pain and foot discomfort caused by the rapid loss of protective subcutaneous fat padding in the feet during GLP-1 weight loss therapy. Rapid body fat ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...